Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes

被引：0
|
作者：
Can Hu
Wen-jun Yin
Dai-yang Li
Jun-jie Ding
Ling-yun Zhou
Jiang-lin Wang
Rong-rong Ma
Kun Liu
Ge Zhou
Xiao-cong Zuo
机构：
[1] Central South University,Department of Pharmacy, The Third Xiangya Hospital
[2] Children’s Hospital of Fudan University,Department of Pharmacy
[3] First Affiliated Hospital of Xinjiang Medical University,Department of Pharmacy
[4] Central South University,Center of Clinical Pharmacology, The Third Xiangya Hospital
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Population pharmacokinetics; Tacrolimus; Evaluation; Renal transplant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1437 / 1447
页数：10
相关论文
共 50 条
  • [31] AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS
    Warzyszynska, Karola
    Karpeta, Edyta
    Kosieradzki, Maciej
    TRANSPLANT INTERNATIONAL, 2021, 34 : 257 - 257
  • [32] Prediction of Tacrolimus Drug Dosing and Metabolism based on CYP3A5 Polymorphism in Indian Renal Transplant Recipients
    Patel, Mohan
    Goswami, Jitendra
    Balwani, Manish
    Gumber, Manoj
    TRANSPLANTATION, 2018, 102 : S92 - S92
  • [33] The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
    Prytula, Agnieszka A.
    Cransberg, Karlien
    Bouts, Antonia H. M.
    van Schaik, Ron H. N.
    de Jong, Huib
    de Wildt, Saskia N.
    Mathot, Ron A. A.
    CLINICAL PHARMACOKINETICS, 2016, 55 (09) : 1129 - 1143
  • [34] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [35] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [36] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [37] CYP3A5 GENOTYPE IS NOT RELATED TO THE INTRA-PATIENT VARIABILITY OF TACROLIMUS CLEARANCE IN RENAL TRANSPLANT RECIPIENTS
    Spierings, Natalia M. K.
    Pashaee, Nilufar
    Bouamar, Rachida
    Hesselink, Dennis A.
    Roodnat, Joke I.
    van Schaik, Ron H. N.
    Weimar, Willem
    Holt, David W.
    MacPhee, Iain A. M.
    van Gelder, Teun
    TRANSPLANT INTERNATIONAL, 2011, 24 : 80 - 81
  • [38] A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients
    Barry, Arden
    Levine, Marc
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 708 - 714
  • [39] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [40] Impact of POR*28 Variant on Tacrolimus Pharmacokinetics in Kidney Transplant Patients with Different CYP3A5 Genotypes
    Everton, Janaina B. F.
    Patricio, Fernando J. B.
    Faria, Manuel S.
    Ferreira, Teresa C. A.
    Filho, Natalino Salgado
    Silva, Gyl E. B.
    Romao, Elen A.
    Magalhaes, Marcelo
    CURRENT DRUG METABOLISM, 2022, 23 (03) : 233 - 241
12345